Ancylostomiasis

Ancylostomiasis
ICD-10	B76.0
ICD-9	126.9
eMedicine	ped/96
MeSH	D000724

WikiDoc Resources for Ancylostomiasis
Articles
Most recent articles on Ancylostomiasis Most cited articles on Ancylostomiasis Review articles on Ancylostomiasis Articles on Ancylostomiasis in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ancylostomiasis Images of Ancylostomiasis Photos of Ancylostomiasis Podcasts & MP3s on Ancylostomiasis Videos on Ancylostomiasis
Evidence Based Medicine
Cochrane Collaboration on Ancylostomiasis Bandolier on Ancylostomiasis TRIP on Ancylostomiasis
Clinical Trials
Ongoing Trials on Ancylostomiasis at Clinical Trials.gov Trial results on Ancylostomiasis Clinical Trials on Ancylostomiasis at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ancylostomiasis NICE Guidance on Ancylostomiasis NHS PRODIGY Guidance FDA on Ancylostomiasis CDC on Ancylostomiasis
Books
Books on Ancylostomiasis
News
Ancylostomiasis in the news Be alerted to news on Ancylostomiasis News trends on Ancylostomiasis
Commentary
Blogs on Ancylostomiasis
Definitions
Definitions of Ancylostomiasis
Patient Resources / Community
Patient resources on Ancylostomiasis Discussion groups on Ancylostomiasis Patient Handouts on Ancylostomiasis Directions to Hospitals Treating Ancylostomiasis Risk calculators and risk factors for Ancylostomiasis
Healthcare Provider Resources
Symptoms of Ancylostomiasis Causes & Risk Factors for Ancylostomiasis Diagnostic studies for Ancylostomiasis Treatment of Ancylostomiasis
Continuing Medical Education (CME)
CME Programs on Ancylostomiasis
International
Ancylostomiasis en Espanol Ancylostomiasis en Francais
Business
Ancylostomiasis in the Marketplace Patents on Ancylostomiasis
Experimental / Informatics
List of terms related to Ancylostomiasis

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Ancylostomiasis is the condition of infection by Ancylostoma hookworms.

Diagnosis

They commonly infect the skin, eyes, and viscera in humans.

• Ancylostoma brasiliensis causes cutaneous larva migrans.

• Toxocara causes visceral larva migrans.

Causes

The infection is usually contracted by persons walking barefoot over contaminated soil. In penetrating the skin, the larvae may cause an allergic reaction. It is from the itchy patch at the site of entry that the early infection gets its nickname "ground itch". Once larvae have broken through the skin, they enter the bloodstream and are carried to the lungs. (Unlike ascarids, however, hookworms do not usually cause pneumonia.) The larvae migrate from the lungs up the windpipe to be swallowed and carried back down to the intestine. If humans come into contact with larvae of the dog hookworm or the cat hookworm, or of certain other hookworms that do not infect humans, the larvae may penetrate the skin.The larvae are unable to complete their migratory cycle in humans. Instead, the larvae migrate just below the skin producing snake-like markings. This is referred to as a creeping eruption or cutaneous larva migrans.

Symptoms

In children (or adults) who walk barefoot, the hookworm can penetrate the sole of the foot and cause a lesion. The larva will then begin to mature while it moves towards the intestines. As in dogs, the hookworm will attach to the intestinal wall. Humans who have become infected will show symptoms of intestinal bleeding, abdominal pains, anemia, sever diarrhea and malnutrition.

Treatment

The drug of choice for the treatment of hookworm disease is mebendazole which is effective against both species, and in addition, will remove the intestinal worm Ascaris also, if present. The drug is very efficient, requiring only a single dose and is inexpensive, the perfect drug. However, treatment requires more than giving the anthelmintic, the patient should also receive dietary supplements to improve their general level of health, in particular iron supplementation is very important. Iron is an important constituent of a multitude of enzyme systems involved in energy metabolism, DNA synthesis and drug detoxification.

As mentioned earlier larval migrans or as it is also known, creeping eruption, is also a very uncomfortable symptom of this disease, and can also be caused by invasion of hookworms from other animals such as cats and dogs. Because they are in an abnormal host they do not mature to adults but instead migrate through the skin until killed by the host's inflammatory response. This causes local intense itching. Topical treatment with thiabendazole ointment is very effective in controlling this condition.

Control of this parasite should be directed against reducing the level of environmental contamination. Treatment of heavily infected individuals is one way to reduce the source of contamination (one study has estimated that 60% of the total worm burden resides in less than 10% of the population). Other obvious methods are to improve sanitary condition, e.g. latrines, but also convincing people to use them by maintaining them in a serviceable form making them conducive to use. Hookworms still account for high proportion of debilitating disease in the tropics and 50-60,000 deaths per year can be attributed to this disease.